262 related articles for article (PubMed ID: 32226376)
1. Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain
Serapide MF; L'Episcopo F; Tirolo C; Testa N; Caniglia S; Giachino C; Marchetti B
Front Aging Neurosci; 2020; 12():24. PubMed ID: 32226376
[TBL] [Abstract][Full Text] [Related]
2. Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease.
Marchetti B
Redox Biol; 2020 Sep; 36():101664. PubMed ID: 32863224
[TBL] [Abstract][Full Text] [Related]
3. Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Cossetti C; D'Adamo P; Zardini E; Andreoni L; Ihekwaba AE; Serra PA; Franciotta D; Martino G; Pluchino S; Marchetti B
Neurobiol Dis; 2011 Feb; 41(2):508-27. PubMed ID: 21056667
[TBL] [Abstract][Full Text] [Related]
4. Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration.
'Episcopo FL; Tirolo C; Testa N; Caniglia S; Morale MC; Marchetti B
Curr Aging Sci; 2013 Feb; 6(1):45-55. PubMed ID: 23895521
[TBL] [Abstract][Full Text] [Related]
5. Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling.
L'Episcopo F; Tirolo C; Peruzzotti-Jametti L; Serapide MF; Testa N; Caniglia S; Balzarotti B; Pluchino S; Marchetti B
Stem Cells; 2018 Aug; 36(8):1179-1197. PubMed ID: 29575325
[TBL] [Abstract][Full Text] [Related]
6. Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair.
Marchetti B; L'Episcopo F; Morale MC; Tirolo C; Testa N; Caniglia S; Serapide MF; Pluchino S
Eur J Neurosci; 2013 May; 37(10):1550-63. PubMed ID: 23461676
[TBL] [Abstract][Full Text] [Related]
7. A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection.
L'episcopo F; Serapide MF; Tirolo C; Testa N; Caniglia S; Morale MC; Pluchino S; Marchetti B
Mol Neurodegener; 2011 Jul; 6():49. PubMed ID: 21752258
[TBL] [Abstract][Full Text] [Related]
8. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease.
Marchetti B
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477246
[TBL] [Abstract][Full Text] [Related]
9. Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.
L'Episcopo F; Tirolo C; Serapide MF; Caniglia S; Testa N; Leggio L; Vivarelli S; Iraci N; Pluchino S; Marchetti B
Front Aging Neurosci; 2018; 10():12. PubMed ID: 29483868
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease, aging and adult neurogenesis: Wnt/β-catenin signalling as the key to unlock the mystery of endogenous brain repair.
Marchetti B; Tirolo C; L'Episcopo F; Caniglia S; Testa N; Smith JA; Pluchino S; Serapide MF
Aging Cell; 2020 Mar; 19(3):e13101. PubMed ID: 32050297
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.
L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Serapide MF; Pluchino S; Marchetti B
Stem Cells; 2014 Aug; 32(8):2147-63. PubMed ID: 24648001
[TBL] [Abstract][Full Text] [Related]
12. Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation.
L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Impagnatiello F; Pluchino S; Marchetti B
J Neurosci; 2013 Jan; 33(4):1462-85. PubMed ID: 23345222
[TBL] [Abstract][Full Text] [Related]
13. "Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications.
Marchetti B; Giachino C; Tirolo C; Serapide MF
Aging Cell; 2022 Apr; 21(4):e13575. PubMed ID: 35262262
[TBL] [Abstract][Full Text] [Related]
14. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease.
Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S
Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346
[TBL] [Abstract][Full Text] [Related]
15. Dickkopf 3 Promotes the Differentiation of a Rostrolateral Midbrain Dopaminergic Neuronal Subset In Vivo and from Pluripotent Stem Cells In Vitro in the Mouse.
Fukusumi Y; Meier F; Götz S; Matheus F; Irmler M; Beckervordersandforth R; Faus-Kessler T; Minina E; Rauser B; Zhang J; Arenas E; Andersson E; Niehrs C; Beckers J; Simeone A; Wurst W; Prakash N
J Neurosci; 2015 Sep; 35(39):13385-401. PubMed ID: 26424886
[TBL] [Abstract][Full Text] [Related]
16. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
Singh S; Mishra A; Shukla S
Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling.
Mishra A; Singh S; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S
Neurochem Int; 2019 Oct; 129():104463. PubMed ID: 31078578
[TBL] [Abstract][Full Text] [Related]
18. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
19. Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.
L'Episcopo F; Tirolo C; Caniglia S; Testa N; Morale MC; Serapide MF; Pluchino S; Marchetti B
J Mol Cell Biol; 2014 Feb; 6(1):13-26. PubMed ID: 24431301
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
